JUSTICE FOR THE VICTIMS OF LIVERPOOL CARE PATHWAY

by Wayne Smith in Bognor Regis, England, United Kingdom

Not quite
Unfortunately this project was not successful.

TO TAKE LEGAL ACTION AGAINST THE PEOPLE RESPONSIBLE FOR MY FATHERS DEATH ... GROSS NEGLIGENCE MANSLAUGHTER / CORPORATE MANSLAUGHTER

by Wayne Smith in Bognor Regis, England, United Kingdom

My father was prescribed 

GLYCOPYRRONIUM BROMIDE INJECTION for Secretions. 

Not only is it the wrong form of GLYCOPYRRONIUM for Secretions. 

It should be the Oral/Powder version. 

Source NICE & Medicines.org

The injected version is a pre-operation medication.

In the medical records my father did not have Secretions

In the post mortem my father did not have Secretions.

 

A specialist EoLC Nurse who trains other EoLC Nurses 

Has told me GLYCOPYRRONIUM BROMIDE 

should never be prescribed without the anti dote

Neostigmine Methylsulfate Injection,   

In case of overdose or adverse reaction

No anti dote was prescribed.

 

My father was also prescribed on the same prescription

MIDAZOLAM for agitation

Again in the medical records 

My father did not have agitation.

 

MIDAZOLAM shouldn't be prescribed for patients over 60

And only in clinical conditions in case of over dose or adverse reaction.

 

If it is prescribed the maximum dose is 3.5mg

My father was prescribed 10mg every 4 hours. 

Source Medicines.org

 

Not to someone who is 82 & in their own home.

Or a Hospice without these facilities.

Again no anti dote was prescribed.

 

MIDAZOLAM is used in every case of 

Execution by Lethal Injection in the USA.

 

In combination with :

 

PROPOFOL : 

The drug which famously killed both Michael Jackson and Joan Rivers.

 

HYDROMORPHONE :

Which has a near identical chemical formula to 

GLYCOPYR-RONIUM BROMIDE :

 

VERCU-RONIUM BROMIDE :

 

ROCU-RONIUM BROMIDE :

 

PANCU-RONIUM BROMIDE :

 

You can see a distinct pattern emerging here ...

 

I have evidence GLYCOPYRRONIUM BROMIDE INJECTION

And MIDAZOLAM are still being used incorrectly.

 

Both drugs are Unlicensed Restricted Specialist Use Only.

And can not be given without the patients informed consent.

Source : NMC

 

No consent was given ...

 

MIDAZOLAM & VARIANTS of GLYCOPYRRONIUM BROMIDE

Pfizer declares 7 drugs off limits for executions

by Eric Palmer | 

May 16, 2016 9:09am

When Pfizer last year bought Hospira in a $15 billion deal, it got the world's’ largest manufacturer of sterile injectable drugs. It also got 7 potentially deadly drugs often used in execution cocktails. Pfizer has now made it clear those drugs are not for sale for executions.

One by one, the makers of the certain lethal drugs have severed the supply chain links with U.S. states that use them for executions. With the posting of its policy restricting their sales, Pfizer became the last of about 25 FDA-approved makers globally to officially cut off access, an expert told The New York Times. Hospira had such a policy in place for years to restrict the sales.

Pfizer on Friday posted its policy, saying that it will sell the drugs only to a handful of specialty drug distributors who contractually agree not to resell them for executions and to verify their buyers. Pfizer said it will continually monitor sales to make every effort to prevent the drugs from being diverted to death sentences.

“Pfizer makes its products to enhance and save the lives of the patients we serve. Consistent with these values, Pfizer strongly objects to the use of its products as lethal injections for capital punishment,” Pfizer said in its position paper.

Pfizer said the drugs it is restricting are pancuronium bromide, potassium chloride, propofol, midazolam, hydromorphone, rocuronium bromide and vecuronium bromide, “specific products that have been part of, or considered by some states for their lethal injection protocols.”

Organizations, particularly in Europe, have for years been putting pressure on drug makers that had not put special measures into place to restrict the drugs, often trying to publicly shame them. Holland-based ABP, the world's third-largest employees' pension fund, had been in a back-and-forth with Mylan about its manufacture of rocuronium bromide, which has been used for executions. When it learned that a Virginia prison had stockpiled the drug, the fund sold of its small position in the company.

Hospira was well schooled in the controversy when Pfizer bought it. Under pressure, Hospira in 2011 stopped manufacturing sodium thiopental in the U.S. It had planned to resume production in Italy, strictly to be used for hospital use, but then decided it was going to be difficult to assure prisons didn’t get it, so it quashed that plan.

Danish drugmaker Lundbeck considered stopping production of Nembutal but then relented, citing concerns of doctors about patients with epilepsy they said needed the drug. It put in strict restrictions on wholesalers instead.

But those policies have not been foolproof. Sometimes, third-party buyers have acquired the execution drugs and resold them to prisons. In 2013, German drugmaker Fresenius Kabi scolded a U.S. wholesaler after it accidentally sold its anesthetic propofol to the state of Missouri, which intended to use it for executions. Fresenius then withheld shipping the drug to the wholesaler, instead shipping it directly to its hospital clients to make sure they did not suffer shortages.


Dear Mr Smith

I refer to our previous correspondence in this matter.  I apologise for the delay in responding to you but I have needed to look into the concerns that you raised surrounding Mr Smith’s death.

 
Having taken into account the details that you have provided me with I am satisfied that there is reasonable cause to suspect that the circumstances leading up to Mr Smith’s death may have resulted in an unnatural death.  It is therefore on that basis that I propose to formally open an Inquest into Mr Smith’s death on Monday with the hearing taking place in November.  Full details will be provided to you after the Inquest is opened.
 

The Police will be assisting with the investigation and taking statements from all concerned and these will be disclosed to you.
 

In order to explain the process to you and how the investigation will be conducted I think it would  be beneficial if we arranged a meeting at my offices.  I would also like DS Williams from Sussex Police to be in attendance along with my Coroner’s officer, Lyn Ralfe.  Could you confirm your availability on Mon, Tues or Weds next week.

 
I look forward to hearing from you.


Kind regards

Penelope Schofield

Senior Coroner


National Patient Safety Agency

Rapid Response Report

Reducing risk of overdose with midazolam injection in adults

Reference number
1074
Central Alert System (CAS) reference
NPSA/2008/RRR011
09 December 2008
Action date : 09 June 2009
DH Gateway reference
NPSA/2008/RRR011
Type : Alert
 




This Rapid Response Report alerts all healthcare organisations using midazolam injection for adult conscious sedation to the risk of overdose.

 

The presentation of high-strength midazolam as 5mg/ml (2ml and 10ml ampoules) or 2mg/ml (5ml ampoule) exceeds the dose required for most patients. There is a risk of administering  the entire contents of high-strength ampoules, when only a fraction of this dose is required.

 

The National Reporting and Learning Service received 498 patient safety incidents between November 2004 and November 2008 where the dose prescribed or administered to the patient was inappropriate. Three incidents resulted in death.

 

The reversing agent, flumazenil, is frequently used to treat inadvertent benzodiazepine overdose. Occasionally, no account is taken for the shorter half life of flumazenil (compared to midazolam), leading to residual re-sedation.

 

Healthcare organisations should:

Restrict the storage and use of high strength midazolam to clinical areas/situations where its use has been risk-assessed.
Replace the storage and use of high-strength midazolam with low-strength midazolam in other clinical areas.
Clarify guidance on the use of midazolam. Ensure that the risks are fully assessed.
Ensure that staff involved in sedation techniques have the necessary skills.
Ensure that flumazenil is available where midazolam is used. Audit the use of flumazenil as a marker of excessive dosing of midazolam.
Ensure that sedation is covered by organisational policy. Assign overall responsibility to a senior clinician.


These Figures were done by one of my fathers GP's
Dr Beth Meek

For Coastal West Sussex Clinical Commissioning Group



National Average Deaths 20 bed Hospice approx 245
St Barnabas House Worthing 782

National Average Deaths 14 bed Hospice approx 170
St Wilfrid's Hospice Chichester 559


CWS CCG Figures 2012 : Page 20


https://www.coastalwestsussexccg.nhs.uk/domains/coastal-west-sussex-ccg.org.uk/local/media/documents/misc/EOLC_feedback_for_November_public_event.pdf

Got an idea like this?

Over £200 million has been raised from our crowd to support the projects they love! Plus tens of millions more unlocked by our partners.